The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Open accessAbstract
BACKGROUND: Patients with arthritis and vascular disease may receive both low-dose aspirin and other nonsteroidal antiinflammatory drugs. We therefore investigated potential interactions between aspirin and commonly prescribed arthritis therapies METHODS: We administered the following combinations of drugs for six days: aspirin (81 mg every morning) two hours before ibuprofen (400 mg every morning) and the same medications in the reverse order; aspirin two hours before acetaminophen (1000 mg every morning) and the same medications in the reverse order; aspirin two hours before the cyclooxygenase-2 inhibitor rofecoxib (25 mg every morning) and the same medications in the reverse order; enteric-coated aspirin two hours before ibuprofen (400 mg three times a day); and enteric-coated aspirin two hours before delayed-release diclofenac (75 mg twice daily) RESULTS: Serum thromboxane B(2) levels (an index of cyclooxygenase-1 activity in platelets) and platelet aggregation were maximally inhibited 24 hours after the administration of aspirin on day 6 in the subjects who took aspirin before a single daily dose of any other drug, as well as in those who took rofecoxib or acetaminophen before taking aspirin. In contrast, inhibition of serum thromboxane B(2) formation and platelet aggregation by aspirin was blocked when a single daily dose of ibuprofen was given before aspirin, as well as when multiple daily doses of ibuprofen were given. The concomitant administration of rofecoxib, acetaminophen, or diclofenac did not affect the pharmacodynamics of aspirin CONCLUSIONS: The concomitant administration of ibuprofen but not rofecoxib, acetaminophen, or diclofenac antagonizes the irreversible platelet inhibition induced by aspirin. Treatment with ibuprofen in patients with increased cardiovascular risk may limit the cardioprotective effects of aspirin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It can also antagonize the platelet inhibition induced by low dose aspirin and lessens its cardioprotective effect (46).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A. S., Shapiro, D., Burgos‐Vargas, R., Davis, B. R., Day, R. O., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,014
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,572
Self-citationMcAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S. C., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,304
Self-citationThe X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,270
Patrono, C., Coller, B. S., Dalen, J. E., Gerald, G. A. F., Fuster, V., Gent, M., Hirsh, J., & Roth, G. J. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.39s · Cited by 961
Patrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 931
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A. B., Barnett, J. W., Chow, J., Ramesha, C. S., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 620
Catella-Lawson, F., McAdam, B. F., Morrison, B. W., Kapoor, S. C., Kujubu, D. A., Antes, L. M., Lasseter, K. C., Quan, H., Gertz, B. J., & FitzGerald, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 596
Self-citation
Flagged first, then by citations
Research works printed but not linked: 7
- Singh G, 1999, J Rheumatol, 26, 18
- Patrignani P, 1999, J Physiol Pharmacol, 50, 661
- Pathmakanthan S, 1998, Ir Med J, 91, 58
- Patrignani P, 1994, J Pharmacol Exp Ther, 271, 1705
- Sciulli MG, Patrignani P, Seta F, et al. Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells in vitro. In: Proceedings of the 11th International Conference on Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications, Florence, Italy, June 4–8, 2000:38. abstract.
- Reilly IAG, 1987, Blood, 69, 180, 10.1182/blood.V69.1.180.180 · DOI
- Catella-Lawson F, 1999, J Pharmacol Exp Ther, 289, 735
Cited by
Sorted by citations
Items 701–800 of 1,000
Kurth, T., Hennekens, C. H., Buring, J. E., & Gaziano, J. M. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0009-0 · Cited by 14
Chogle, A. R., & Chakravarty, A. (2007) · PubMed · Cited by 14
Gillet, B., Ianotto, J., Mingant, F., Didier, R. J., Gilard, M., Ugo, V., Lippert, É., & Galinat, H. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.04.006 · Cited by 14
Thomas, D., & Giugliano, R. P. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.08.023 · Cited by 14
Heart Rate Variability in Patients With Stable Coronary Artery Disease and Aspirin Resistance
Durmaz, T., Keleş, T., Özdemır, Ö., Bayram, N., Akçay, M., Yeter, E., & Bozkurt, E. (2008) · International Heart Journal · doi:10.1536/ihj.49.413 · Cited by 14
Symposium: conference on the science and policy of performance-enhancing products
Fomous, C., Costello, R. B., & Coates, P. M. (2002) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200210000-00022 · Cited by 14
An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors
Williams, G. W. (2005) · Current Pain and Headache Reports · doi:10.1007/s11916-005-0017-4 · Cited by 14
Mukherjee, D. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-07-0384 · Cited by 14
Hoxha, M., Buccellati, C., Capra, V., Garella, D., Cena, C., Rolando, B., Fruttero, R., Carnevali, S., Sala, A., Rovati, G. E., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.012 · Cited by 14
Aspirin Resistance: A Review Of Diagnostic Methodology, Mechanisms, and Clinical Utility
Schwartz, K. A. (2006) · Advances in clinical chemistry · doi:10.1016/s0065-2423(06)42003-5 · Cited by 14
Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?
Chioléro, A., Burnier, M., & Maillard, M. P. (2002) · Expert Opinion on Drug Safety · doi:10.1517/14740338.1.1.45 · Cited by 14
Pain management in the hospitalized patient
Li, J. M. W. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00025-1 · Cited by 14
Drug–drug interactions involving antiplatelet agents
Bates, E. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00470-6 · Cited by 14
Remuzzi, G., Schiaffino, S., Santoro, M. G., FitzGerald, G. A., Melino, G., & Patrono, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.987816 · Cited by 16
Self-citationPham, T. T., Miller, M. J., Harrison, D. L., Lloyd, A. E., Crosby, K. M., & Johnson, J. L. (2012) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12014 · Cited by 13
Antiplatelet agents in hemodialysis
MIGLIORI, M., Cantaluppi, V., Scatena, A., & Panichi, V. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0367-5 · Cited by 13
Monitoring antiplatelet therapy: where are we now?
Marcucci, R., Berteotti, M., Gragnano, F., Galli, M., Cavallari, I., Renda, G., Capranzano, P., Santilli, F., Capodanno, D., Angiolillo, D. J., et al. (2022) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001406 · Cited by 13
Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes
Worthley, M. I. (2010) · Patient Related Outcome Measures · doi:10.2147/prom.s9834 · Cited by 13
Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production
Riondino, S., Trifirò, E., Principessa, L., Mascioletti, S., Renzo, L. D., Gaudio, C., Biasucci, L. M., Crea, F., & Pulcinelli, F. M. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2007.12.011 · Cited by 13
Labuz-Roszak, B. M., Pierzchała, K., & Tyrpień-Golder, K. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0012-2 · Cited by 14
Update on the clinical pharmacology of etoricoxib, a potent cyclooxygenase-2 inhibitor
Escudero‐Contreras, A., Cervantes, J. V.-M., & Collantes‐Estévez, E. (2007) · Future Rheumatology · doi:10.2217/17460816.2.6.545 · Cited by 13
Li, W., Lian, Y.-Y., Yue, W.-J., Qu, Y., Qi, Y., Meng, Q.-G., & Zhao, C.-B. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700223 · Cited by 13
Derle, E., Öcal, R., Kibaroğlu, S., Çelikkol, C., Bayraktar, N., Verdi, H., Ataç, F. B., & Can, U. A. (2016) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000404 · Cited by 13
Do we need antiplatelet therapy in thrombocytosis? Contra
Scharf, R. E. (2016) · Hämostaseologie · doi:10.5482/hamo-16-06-0016 · Cited by 13
Schmitz, A., Romann, L., Kienbaum, P., Pavlaković, G., Werdehausen, R., & Hohlfeld, T. (2016) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000581 · Cited by 13
Wand, S., Adam, E., Wetz, A. J., Meybohm, P., Kunze-Szikszay, N., Zacharowski, K. D., Popov, A., Moritz, A., Moldenhauer, L., Kaiser, J., et al. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029617693939 · Cited by 13
Jafarnezhad‐Ansariha, F., Yekaninejad, M. S., Jamshidi, A., Mansouri, R., Vojdanian, M., Mahmoudi, M., Fattahi, M. J., Hashemi, S. N., Rehm, B. H. A., Matsuo, H., et al. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0386-4 · Cited by 13
The safety of lumiracoxib when used in the treatment of arthritis
Doggrell, S. A. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.2.347 · Cited by 13
Cheng, G., Shan, J., Xu, G. M., Liu, P., Zhou, Y., Zhu, Y., & Lu, X. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00823.x · Cited by 12
Galliard-Grigioni, K. S., Fehr, M., & Reinhart, W. H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.036 · Cited by 13
Durán, J., Peloquin, C. E., Zhang, Y., & Felson, D. T. (2017) · The Journal of Rheumatology · doi:10.3899/jrheum.160930 · Cited by 13
Nonsteroidal Anti‐Inflammatory Drugs and the Heart: What Is the Danger?
Mukherjee, D. (2008) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2008.07453.x · Cited by 13
Jermany, J., Branson, J., Schmouder, R., Guillaume, M., & Rordorf, C. M. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005280377 · Cited by 13
A Benefit-Risk Assessment of Agents Used in the Secondary Prevention of Stroke
MacWalter, R. S., & Shirley, C. P. (2002) · Drug Safety · doi:10.2165/00002018-200225130-00005 · Cited by 13
Rofecoxib exerts no effect on platelet plug formation in healthy volunteers.
Homoncik, M., Malec, M., Marsik, C. L., Sycha, T., Anzenhofer, S., Gustorff, B., & Jilma, B. (2003) · PubMed · Cited by 13
Antiplatelet Therapy in the Management of Myeloproliferative Neoplasms
Álvarez‐Larrán, A., & Besses, C. (2014) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-014-0226-1 · Cited by 12
Wan, E. Y. F., Yu, E. Y. T., Chan, L. S., Mok, A. H. Y., Wang, Y., Chan, E. W., Wong, I. C. K., & Lam, C. L. K. (2022) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2142 · Cited by 12
Myers, R. I. (2005) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2005.11928091 · Cited by 12
Du, J., Li, X., Zhang, W., Yang, Y., Wu, Y., Li, W., Peng, J., & Li, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.069 · Cited by 12
The Thrombotic and Arrhythmogenic Risks of Perioperative NSAIDs
Gerstein, N. S., Gerstein, W. H., Carey, M. C., Lam, N. C. K., Ram, H., Spassil, N. R., & Schulman, P. M. (2013) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2013.05.018 · Cited by 12
Rothschild, B. M. (2011) · Reumatismo · doi:10.4081/reumatismo.2004.89 · Cited by 12
Jia, Y., Ge, P., Zhou, H., Ji, J., Tai, T., Gu, T., Zhu, T., Li, Y., Mi, Q., Huang, B., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108906 · Cited by 12
Platelet function, antiplatelet therapy and clinical outcomes: to test or not to test?
de Gaetano, G., & Cerletti, C. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02655.x · Cited by 12
Overcoming aspirin treatment failure in diabetes
Linden, M. D., & Tran, H. A. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.731377 · Cited by 229
Aspirin Resistance: Disparities and Clinical Implications
Airee, A., Draper, H. M., & Finks, S. W. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.8.999 · Cited by 12
In Vitro Inflammation Inhibition Model Based on Semi-Continuous Toll-Like Receptor Biosensing
Jeon, J.-W., Ha, U., & Paek, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105212 · Cited by 12
Platelets and new antiplatelet drugs
Reiter, R. A., & Jilma, B. (2005) · Therapy · doi:10.1586/14750708.2.3.465 · Cited by 12
Matsumoto, A. K., Melian, A., Shah, A. K., & Curtis, S. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x219625 · Cited by 12
Aspirin resistance: Where are we now?
Abacı, O., & Kılıçkesmez, K. (2013) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2013.107 · Cited by 12
Variability in Individual Responsiveness to Aspirin: Clinical Implications and Treatment
Coma-Canella, I., & Velasco, A. (2007) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152907782793590 · Cited by 12
Schrör, K., Weber, A., & Hohlfeld, T. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.12.017 · Cited by 12
Ellison, J. A., & Dager, W. E. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.06496.x · Cited by 12
Pharmacological bases of combining nonsteroidal antiinflammatory drugs and paracetamol
Tena‐Garitaonaindia, M., Rubio, J. M., Martínez-Plata, E., Martínez‐Augustin, O., & de Medina, F. S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118069 · Cited by 13
Variability in the response to antiplatelet treatment in diabetes mellitus
Davı̀, G., Vazzana, N., & Sestili, S. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.01.008 · Cited by 10
Inhibition of Antiplatelet Effects of Aspirin by Nonopioid Analgesics
Hohlfeld, T., & Schrör, K. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.21 · Cited by 11
Fatal Thrombosis of a Flow Diverter due to Ibuprofen-related Antagonization of Acetylsalicylic Acid
Martínez-Moreno, R., Aguilar, M., Wendl, C. M., Bäzner, H., Ganslandt, O., & Henkes, H. H. (2015) · Clinical Neuroradiology · doi:10.1007/s00062-015-0487-7 · Cited by 11
Perioperative management of a neurosurgical patient requiring antiplatelet therapy
Than, K. D., Rohatgi, P., Wilson, T. J., & Thompson, B. G. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.12.018 · Cited by 11
Non Steroidal Anti Inflammatory Drugs-An Overview
Rahman, M., Alam, M. B., Islam, M. A., & Haque, A. A. (1970) · Journal of Medicine · doi:10.3329/jom.v7i1.1358 · Cited by 11
Antithrombotic Drug Therapy in Cardiovascular Disease
Askari, A. T., & Lincoff, A. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-235-3 · Cited by 11
Duval, C., Rahouadj, R., Nouvel, C., & Six, J. (2017) · International Journal of Polymeric Materials · doi:10.1080/00914037.2017.1354197 · Cited by 11
Jo, H. A., Kim, D. K., Park, S., Kim, Y., Han, S. S., Yang, B. R., Choi, S.-H., Kim, M.-S., Lee, J., Lee, H., et al. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz276 · Cited by 11
High on-treatment platelet reactivity to aspirin in patients after myocardial infarction
Stolarek, W., Kasprzak, M., Sikora, J., Siemińska, E., & Grześk, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112618 · Cited by 11
Cardiovascular Pharmacology Core Reviews
Gaglia, M. A., & Clavijo, L. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413503043 · Cited by 12
Benefit-Risk Assessment of Rofecoxib in the Treatment of Osteoarthritis
Schmidt, H., Woodcock, B. G., & Geißlinger, G. (2004) · Drug Safety · doi:10.2165/00002018-200427030-00003 · Cited by 11
Sørensen, R., Abildstrom, S. Z., Torp-Pedersen, C. T., & Gislason, G. (2008) · The Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000305054.50506.59 · Cited by 11
Ischemic Stroke in Patients Receiving Aspirin
Lereis, V. P., Ameriso, S. F., Povedano, G. P., & Ameriso, S. F. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2011.05.009 · Cited by 11
Oldenhof, J., Hochberg, M. C., Schiff, M. H., & Brune, K. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.481249 · Cited by 11
Aspirin resistance: is this term meaningful?
Violi, F., & Pignatelli, P. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000239704.17427.9b · Cited by 11
Širvinskas, E., Veikutienė, A., Grybauskas, P., Cimbolaitytė, J., Mongirdienė, A., Veikutis, V., & Ralienė, L. (2006) · Perfusion · doi:10.1191/0267659106pf845oa · Cited by 11
Platelet function testing in pigs using the Multiplate® Analyzer
Heringer, S., Kabelitz, L., Krämer, M., Nikoubashman, O., Brockmann, M. A., Kirschner, S., & Wiesmann, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222010 · Cited by 11
Aspirin response and failure in diabetic patients with cardiovascular disease
Yan, Y., & Phillips, D. R. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.005 · Cited by 11
Antman, E. M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.034 · Cited by 11
Current Strategies to Reduce Gastrointestinal Bleeding Risk Associated with Antiplatelet Agents
Parekh, P. J., Oldfield, E. C., & Johnson, D. A. (2015) · Drugs · doi:10.1007/s40265-015-0455-1 · Cited by 10
Duong, M., Abouelfath, A., Lassalle, R., Droz‐Perroteau, C., Blin, P., & Moore, N. D. (2018) · Drug Safety · doi:10.1007/s40264-018-0686-7 · Cited by 10
Tosetto, A., Rocca, B., Petrucci, G., Betti, S., Soldati, D., Rossi, E., Timillero, A., Cavalca, V., Porro, B., Iurlo, A., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2485 · Cited by 10
Scanzello, C. R., Moskowitz, N. K., & Gibofsky, A. (2007) · Current Pain and Headache Reports · doi:10.1007/s11916-007-0227-z · Cited by 10
Influence of Nonsteroidal Anti-inflammatory Drugs on the Antiplatelet Effects of Aspirin in Rats
Akagi, Y., Nio, Y., Shimada, S., & Aoyama, T. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.233 · Cited by 10
Goldstein, J. L., Whellan, D. J., Scheiman, J. M., Cryer, B., Eisen, G. M., Lanas, Á., & Fort, J. G. (2016) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12172 · Cited by 10
Tacconelli, S., Dovizio, M., Francesco, L. D., Meneguzzi, A., D’Agostino, I., Evangelista, V., Manarini, S., Capone, M. L., Grossi, L., Porreca, E., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1075 · Cited by 10
Gawryś, J., Gawryś, K., Szahidewicz-Krupska, E., Derkacz, A., Mochol, J., & Doroszko, A. (2018) · BioMed Research International · doi:10.1155/2018/7902081 · Cited by 10
Mohler, E. R. (2009) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.21995 · Cited by 10
Self-Medication Practices That Alter the Efficacy of Selected Cardiac Medications
Neafsey, P. J. (2004) · Home Healthcare Now · doi:10.1097/00004045-200402000-00007 · Cited by 10
Clinical and biochemical aspirin resistance in patients with recurrent cerebral ischemia
El‐Mitwalli, A., Azzam, H., Abu‐Hegazy, M., Gomaa, M., & Wassel, Y. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.09.025 · Cited by 10
On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1
Burde, T., & Rimon, G. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02450-0 · Cited by 10
Chu, J. W., Wong, C. K., Chambers, J. A. A., Wout, J. V., Herbison, P., & Tang, E. W. (2010) · QJM · doi:10.1093/qjmed/hcq038 · Cited by 10
Nonopioid and adjuvant analgesics in chronic pain management: strategies for effective use
Gordon, D. B. (2003) · Nursing Clinics of North America · doi:10.1016/s0029-6465(02)00095-6 · Cited by 10
Aspirin resistance in coronary heart disease: Current understandings and strategies
Han, Y. (2016) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2016-0002 · Cited by 10
Carnevali, S., Buccellati, C., Bolego, C., Bertinaria, M., Rovati, G. E., & Sala, A. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170602083428 · Cited by 10
Sisodia, P., & Bhatia, R. (2018) · Journal of Stroke Medicine · doi:10.1177/2516608518777017 · Cited by 10
Anticoagulation in the acute and long-term management of Kawasaki disease
Williams, R. V., Tcheng, W. Y., & Minich, L. L. (2004) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2004.08.012 · Cited by 10
The Effect on Comorbidity and Pain in Patients with Osteoarthritis
Kirkness, C. S., Yu, J., & Asche, C. V. (2008) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360280802536649 · Cited by 10
Do Over-the-counter medications for migraine hinder the physician?
Tonore, T. B., King, D. S., & Noble, S. L. (2002) · Current Pain and Headache Reports · doi:10.1007/s11916-002-0014-9 · Cited by 10
Pamuk, Ö. N., & Çakir, N. (2005) · Clinical Rheumatology · doi:10.1007/s10067-005-1167-9 · Cited by 10
Aspirin and Clopidogrel Resistance in Drug Eluting Stent Era
Kim, J., & Yoon, J. (2007) · Korean Circulation Journal · doi:10.4070/kcj.2007.37.4.135 · Cited by 10
Potential Cardiovascular Effects of COX-2 Selective Nonsteroidal Antiinflammatory Drugs
Fowles, R. E. (2003) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/j354v17n02_03 · Cited by 10
Dosing Frequency of Aspirin and Prevention of Heart Attacks and Strokes
Amory, J. K., & Amory, D. W. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.04.023 · Cited by 10
Pharmacology and relevant drug interactions of metamizole
Brinkman, D. J., Hendriksen, L. C., Rigter, I. M., & Hollmann, M. W. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70101 · Cited by 9
Jakl, M. (2016) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2016.7042 · Cited by 9
Anti‐platelet agents: past, present and future
Cox, D. M. (2019) · ISBT Science Series · doi:10.1111/voxs.12529 · Cited by 9
Chen, Y., Wang, Y., Xie, Z., Ming, X., Li, Z., & Kong, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.051 · Cited by 9
Metadata
- Authors
- Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A.
- Affiliations
- University of Pennsylvania (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-12-20
- Volume
- 345
- Issue
- 25
- Pages
- 1809-1817
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2011327495
- Cited by
- 1,394
- References
- 44
- Citations by year
- 2026: 19 · 2025: 15 · 2024: 18 · 2023: 18 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 40 · 2018: 40 · 2017: 46 · 2016: 41 · 2015: 56 · 2014: 46 · 2013: 69 · 2012: 79
- FWCI
- 50.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 5400, HL62250, P01HL062250)
- National Center for Research Resources (M01-RR-00040, M01RR000040)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- aspirin, ibuprofen, cyclooxygenase inhibitors, rofecoxib, diclofenac, paracetamol, drug interactions, platelet aggregation, thromboxane B2, antiplatelet activity, nonsteroidal anti-inflammatory drugs, arthritis treatment, cardiovascular risk, cardioprotection
- MeSH terms
- Acetaminophen, Adult, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Diclofenac, Drug Interactions, Drug Therapy, Combination, Humans, Ibuprofen, Isoenzymes, Lactones, Membrane Proteins, Middle Aged, Platelet Aggregation, Platelet Aggregation Inhibitors, Prostaglandin-Endoperoxide Synthases, Sulfones, Thromboxane B2, Dinoprostone, Cyclooxygenase Inhibitors, Cross-Over Studies, Analgesics, Non-Narcotic, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
